These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 2573424

  • 21. Increased erbB-2 gene copies and expression in multiple stages of breast cancer.
    Iglehart JD, Kraus MH, Langton BC, Huper G, Kerns BJ, Marks JR.
    Cancer Res; 1990 Oct 15; 50(20):6701-7. PubMed ID: 2208136
    [Abstract] [Full Text] [Related]

  • 22. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
    Li BD, Bauer KD, Carney WP, Duda RB.
    J Surg Res; 1993 Mar 15; 54(3):179-88. PubMed ID: 7682635
    [Abstract] [Full Text] [Related]

  • 23. Human breast cancer: correlation study between HER-2/neu amplification and prognostic factors in an unselected population.
    Descotes F, Pavy JJ, Adessi GL.
    Anticancer Res; 1993 Mar 15; 13(1):119-24. PubMed ID: 8097388
    [Abstract] [Full Text] [Related]

  • 24. Amplification of HER-2(erbB-2/neu) oncogene as the most significant prognostic factor in a group of Russian breast cancer patients.
    Imyanitov EN, Chernitsa OI, Serova OM, Nikoforova IF, Pluzhnikova GF, Knyazev PG.
    Neoplasma; 1993 Mar 15; 40(1):35-9. PubMed ID: 7688867
    [Abstract] [Full Text] [Related]

  • 25. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
    Chiba W, Sawai S, Hanawa T, Ishida H, Matsui T, Kosaba S, Watanabe S, Hatakenaka R, Matsubara Y, Funatsu T.
    Gan To Kagaku Ryoho; 1993 Apr 15; 20(6):824-7. PubMed ID: 8098200
    [Abstract] [Full Text] [Related]

  • 26. [Amplification of c-myc and c-erbbeta-2(HER-2/neu) in breast cancer without axillary lymph node metastasis: correlation with other prognostic parameters].
    Lizard-Nacol S, Arnould L, Riedinger JM, Arnal M, Collin F, Guerrin J.
    Bull Cancer; 1994 Sep 15; 81(9):780-4. PubMed ID: 7703567
    [Abstract] [Full Text] [Related]

  • 27. Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer.
    Zhou D, Battifora H, Yokota J, Yamamoto T, Cline MJ.
    Cancer Res; 1987 Nov 15; 47(22):6123-5. PubMed ID: 3664511
    [Abstract] [Full Text] [Related]

  • 28. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ, Aaltomaa S, Syrjänen S, Syrjänen K.
    Anticancer Res; 1993 Nov 15; 13(4):1147-52. PubMed ID: 8102517
    [Abstract] [Full Text] [Related]

  • 29. Heterogeneous expression of erbB-2 messenger RNA in human breast cancer.
    King CR, Swain SM, Porter L, Steinberg SM, Lippman ME, Gelmann EP.
    Cancer Res; 1989 Aug 01; 49(15):4185-91. PubMed ID: 2568168
    [Abstract] [Full Text] [Related]

  • 30. Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas.
    Meyers SL, O'Brien MT, Smith T, Dudley JP.
    Cancer Res; 1990 Sep 15; 50(18):5911-8. PubMed ID: 1975511
    [Abstract] [Full Text] [Related]

  • 31. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.
    Park JB, Rhim JS, Park SC, Kimm SW, Kraus MH.
    Cancer Res; 1989 Dec 01; 49(23):6605-9. PubMed ID: 2573419
    [Abstract] [Full Text] [Related]

  • 32. HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.
    Di Leo A, Gancberg D, Larsimont D, Tanner M, Jarvinen T, Rouas G, Dolci S, Leroy JY, Paesmans M, Isola J, Piccart MJ.
    Clin Cancer Res; 2002 May 01; 8(5):1107-16. PubMed ID: 12006526
    [Abstract] [Full Text] [Related]

  • 33. Hormonal receptors, cell proliferation fraction (Ki-67) and c-erbB-2 amplification in breast cancer. Relationship between differentiation degree and axillary lymph node metastases.
    Sirvent JJ, Santafé M, Salvadó MT, Alvaro T, Raventós A, Palacios J.
    Histol Histopathol; 1994 Jul 01; 9(3):563-70. PubMed ID: 7526910
    [Abstract] [Full Text] [Related]

  • 34. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.
    Courjal F, Cuny M, Simony-Lafontaine J, Louason G, Speiser P, Zeillinger R, Rodriguez C, Theillet C.
    Cancer Res; 1997 Oct 01; 57(19):4360-7. PubMed ID: 9331099
    [Abstract] [Full Text] [Related]

  • 35. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
    Varley JM, Swallow JE, Brammar WJ, Whittaker JL, Walker RA.
    Oncogene; 1987 Oct 01; 1(4):423-30. PubMed ID: 3330785
    [Abstract] [Full Text] [Related]

  • 36. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y, Booser DJ, Sneige N.
    Cancer; 2005 May 01; 103(9):1763-9. PubMed ID: 15786420
    [Abstract] [Full Text] [Related]

  • 37. Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells?
    Tang RP, Kacinski B, Validire P, Beuvon F, Sastre X, Benoit P, dela Rochefordière A, Mosseri V, Pouillart P, Scholl S.
    J Cell Biochem; 1990 Nov 01; 44(3):189-98. PubMed ID: 1980125
    [Abstract] [Full Text] [Related]

  • 38. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.
    Courjal F, Theillet C.
    Cancer Res; 1997 Oct 01; 57(19):4368-77. PubMed ID: 9331100
    [Abstract] [Full Text] [Related]

  • 39. Overexpression of the c-erbB-2 protein in human breast tumor cell lines.
    Hynes NE, Gerber HA, Saurer S, Groner B.
    J Cell Biochem; 1989 Feb 01; 39(2):167-73. PubMed ID: 2565909
    [Abstract] [Full Text] [Related]

  • 40. Oncogene patterns in breast and ovarian carcinomas.
    Csókay B, Papp J, Besznyák I, Bösze P, Sárosi Z, Tóth J, Zalay Z, Oláh E.
    Eur J Surg Oncol; 1993 Dec 01; 19(6):593-9. PubMed ID: 7903645
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.